azomycin has been researched along with 1,7-phenanthroline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freyvogel, TA; Gyr, K | 1 |
| Brindell, M; Brzozowski, T; Krysiak-Foria, O; Mazuryk, O; Ptak-Belowska, A; Stochel, G; Suzenet, F; Żak, A | 1 |
| Alland, D; Bajaj, A; Dhiman, R; Gosain, TP; Hwang, YK; Jung, MG; Kidwai, S; Kumar, P; Kumar, S; Lee, IY; Mawatwal, S; Park, CY; Singh, R; Song, CS; Tiwari, P | 1 |
3 other study(ies) available for azomycin and 1,7-phenanthroline
| Article | Year |
|---|---|
[Diarrhea caused by parasites].
Topics: Acridines; Diarrhea; Emetine; Entamoeba histolytica; Entamoebiasis; Furans; Giardia; Giardiasis; Humans; Insect Vectors; Nitroimidazoles; Phenanthrolines | 1982 |
Nitroimidazole derivatives of polypyridyl ruthenium complexes: Towards understanding their anticancer activity and mode of action.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Mitochondria; Nitroimidazoles; Phenanthrolines; Reactive Oxygen Species; Ruthenium; S Phase | 2017 |
Dual Mechanism of Action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Autophagy; Cell Line, Tumor; Disease Models, Animal; Escherichia coli; Female; Humans; Macrophages; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium smegmatis; Mycobacterium tuberculosis; Nitroimidazoles; Phenanthrolines; Structure-Activity Relationship; THP-1 Cells; Tuberculosis, Multidrug-Resistant | 2017 |